Filtered by vendor Mitel Subscriptions
Filtered by product St 14.2 Subscriptions
Total 4 CVE
CVE Vendors Products Updated CVSS v3.1
CVE-2018-9104 1 Mitel 2 Mivoice Connect, St 14.2 2024-11-21 N/A
A vulnerability in the conferencing component of Mitel MiVoice Connect, versions R1707-PREM SP1 (21.84.5535.0) and earlier, and Mitel ST 14.2, versions GA27 (19.49.5200.0) and earlier, could allow an unauthenticated attacker to conduct a reflected cross-site scripting (XSS) attack due to insufficient validation for the api.php page. A successful exploit could allow an attacker to execute arbitrary scripts.
CVE-2018-9103 1 Mitel 2 Mivoice Connect, St 14.2 2024-11-21 N/A
A vulnerability in the conferencing component of Mitel MiVoice Connect, versions R1707-PREM SP1 (21.84.5535.0) and earlier, and Mitel ST 14.2, versions GA27 (19.49.5200.0) and earlier, could allow an unauthenticated attacker to conduct a reflected cross-site scripting (XSS) attack due to insufficient validation for the signin.php page. A successful exploit could allow an attacker to execute arbitrary scripts.
CVE-2018-9102 1 Mitel 2 Mivoice Connect, St 14.2 2024-11-21 N/A
A vulnerability in the conferencing component of Mitel MiVoice Connect, versions R1707-PREM SP1 (21.84.5535.0) and earlier, and Mitel ST 14.2, versions GA27 (19.49.5200.0) and earlier, could allow an unauthenticated attacker to conduct an SQL injection attack due to insufficient input validation for the signin interface. A successful exploit could allow an attacker to extract sensitive information from the database.
CVE-2018-9101 1 Mitel 2 Mivoice Connect, St 14.2 2024-11-21 N/A
A vulnerability in the conferencing component of Mitel MiVoice Connect, versions R1707-PREM SP1 (21.84.5535.0) and earlier, and Mitel ST 14.2, versions GA27 (19.49.5200.0) and earlier, could allow an unauthenticated attacker to conduct a reflected cross-site scripting (XSS) attack due to insufficient validation for the launch_presenter.php page. A successful exploit could allow an attacker to execute arbitrary scripts.